- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05812989
Modifiers and Mechanisms of Loneliness Interventions
March 26, 2024 updated by: Kathi Heffner, University of Rochester
A specific aim of this research is to identify the role of emotion regulation in response to social threat in caregivers' response to a behavioral coaching intervention for loneliness.
A second aim of the study is to determine the benefit of a digitized, social engagement prioritization tool for improving coaches' intervention fidelity and caregiver outcomes.
This study is funded through the Pilot Award Program of the Rochester Roybal Center for Social Ties & Aging Research, a UR Center funded by the National Institute on Aging by grant P30AG064103.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The objective of this Stage III mechanistic study is to help identify additional modifiable targets and scalable approaches to support further development of highly effective, mechanistic-informed approaches to reducing loneliness and improving social connectedness in caregivers.
This study is a Stage III, 19-month 2 (groups) x 2 (assessment timepoints) randomized clinical trial (RCT) aimed at identifying whether lonely caregivers' capacity, is associated with the degree to which loneliness is reduced in response to social engagement intervention (S-ENG).
Further, the study will address whether a digitized, social engagement prioritization tool (C4C) used in the first session of S-ENG can improve intervention fidelity and
Study Type
Interventional
Enrollment (Estimated)
57
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Kathi L Heffner, PhD
- Phone Number: 585-273-4786
- Email: kathi_heffner@urmc.rochester.edu
Study Contact Backup
- Name: Jeff Swan, MS
- Phone Number: 585-275-6835
- Email: jeffrey_swan@urmc.rochester.edu
Study Locations
-
-
New York
-
Rochester, New York, United States, 14642
- Recruiting
- University of Rochester
-
Contact:
- Kathi L Heffner, PhD
- Phone Number: 585-273-4786
- Email: kathi_heffner@urmc.rochester.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Caregiver (age 50 or older) for a community-dwelling loved one with Alzheimer's disease or related dementia (ADRD), living with (or in close proximity to) the person with ADRD.
- Elevated caregiving distress: above population mean (>11) on 10-item Perceived Stress Scale (PSS-10) and/or at least moderate caregiver strain (score >= 5) on the Modified Caregiver Strain Index.
- Social disconnection: UCLA Loneliness Scale: Short Form score of > 5.
Exclusion Criteria:
- Non-English speaking
- Significant cognitive impairment
- Major cardiovascular conditions that may interfere with reliable assessment of HRV (e.g., congestive heart failure, pacemaker, prior myocardial infarction).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Social Engage Coaching
Social Engage Coaching involves psychoeducation on the importance of social connections for health as well as structured goal setting and problem solving for increasing social connectedness.
|
Participants will complete up to 8 weekly individual Social Engage psychotherapy sessions.
Participants will be allotted up to 3 months to complete all sessions, a time-frame that allows for two weeks without meeting to address life stressors such as illnesses that may pop up.
All sessions are provided via phone or videocall (Zoom).
The first and last session are longer - up to 60 minutes if needed.
Middle sessions are shorter (20-45 minutes).
Engage is a stepped care psychotherapy in that the simplest strategy is taught first-action planning (a derivative of problem solving therapy)-and "barrier strategies" are added only if needed.
Action plans are designed to address loneliness and social isolation in the context of caregiving demands.
|
Active Comparator: Social Engage Coaching with Connect for Caregivers
Social Engage Coaching involves psychoeducation on the importance of social connections for health as well as structured goal setting and problem solving, guided by use of a digitized prioritization tool, for increasing social connectedness.
|
Participants will complete up to 8 weekly individual Social Engage psychotherapy sessions.
Participants will be allotted up to 3 months to complete all sessions, a time-frame that allows for two weeks without meeting to address life stressors such as illnesses that may pop up.
All sessions are provided via phone or videocall (Zoom).
The first and last session are longer - up to 60 minutes if needed.
Middle sessions are shorter (20-45 minutes).
Engage is a stepped care psychotherapy in that the simplest strategy is taught first-action planning (a derivative of problem solving therapy)-and "barrier strategies" are added only if needed.
Action plans are designed to address loneliness and social isolation in the context of caregiving demands.
Participants will complete an individual session with a coach who will use a digitized prioritization tool to help identify goals and an action plan for social connectedness.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Loneliness
Time Frame: 11 weeks
|
UCLA Loneliness Scale Version 3, which assesses self-reported loneliness.
20 items, rated as to how often the participant has felt a certain way in the prior month (e.g., "How often do you feel alone?")
-- "never" (1), "rarely" (2), "sometimes" (3), or "often" (4).
Higher scores indicate greater loneliness.
However, some individual items must be reverse-coded so that higher total scores reflect greater loneliness (i.e., 1=4, 2=3, 3=2, 4=1).
These items (e.g., "How often do you feel there are people you can turn to?") are items 1,5,6,9,10,15,16,19,20.
Total scores range from 20 to 80, with higher scores representing a worse outcome (i.e., greater loneliness).
|
11 weeks
|
High frequency heart rate variability (HF-HRV)
Time Frame: 11 weeks
|
HF-HRV is derived by spectral analysis of the electrocardiograph (ECG) waveform collected during a rest period, and is a measure of parasympathetic control of the heart; Higher resting HF-HRV (absolute power of the high-frequency band (0.15-0.4 Hz) in ms-squared) reflects greater parasympathetic regulation of the heart.
|
11 weeks
|
Dot probe task
Time Frame: 11 weeks
|
Difference in response times (in milliseconds) to dots appearing in the location of a previously shown negative versus the neutral face.
|
11 weeks
|
Affect (valence) from Self-Assessment Manikin
Time Frame: 11 weeks
|
Mean valence score during negatively valenced social pictures.
The Self-Assessment Manikin is a non-verbal pictorial assessment technique that directly measures a person's affect in response to positive, negative, and neutrally valenced pictures.
Affect valence is measured on a 9-point scale: 1 (very unpleasant) - 9 (very pleasant).
|
11 weeks
|
Stroop Task
Time Frame: 11 weeks
|
Difference in response time (ms) to judgments of semantic meaning (positive or negative) of spoken, socially-relevant words between congruent (e.g., negative social word-negative vocal tone) versus incongruent (e.g., positive social word-negative vocal tone) trials, indicating cognitive interference.
|
11 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Flanker Task
Time Frame: 11 weeks
|
During the trials, a decision needs to be made about whether the orientation of a central stimulus is congruent or incongruent with a set of flanking arrows.
Selective attention/cognitive inhibition is indicated by difference between response time (millisecond) on the congruent and incongruent conditions.
|
11 weeks
|
Set-Shifting Task
Time Frame: 11 weeks
|
During each trial, the participant is required to match a stimulus on the top of the screen to one of two stimuli in the lower corners of the screen.
In task-homogeneous blocks, the examinee performs either Task A (e.g., classifying shapes) or Task B (e.g., classifying colors).
In task-heterogeneous blocks, the examinee alternates between the two tasks pseudo-randomly.
Cognitive flexibility (or capacity for task switching) is derived as the difference in response time (milleseconds) between homogeneous and heterogenous blocks.
|
11 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Kathi L Heffner, PhD, University of Rochester
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 18, 2023
Primary Completion (Estimated)
May 1, 2025
Study Completion (Estimated)
May 1, 2025
Study Registration Dates
First Submitted
March 31, 2023
First Submitted That Met QC Criteria
March 31, 2023
First Posted (Actual)
April 14, 2023
Study Record Updates
Last Update Posted (Actual)
March 28, 2024
Last Update Submitted That Met QC Criteria
March 26, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- STUDY00007800
- P30AG064103 (U.S. NIH Grant/Contract)
- P30AG064103-Pilot7 (Other Grant/Funding Number: Rochester Roybal Center for Social Ties & Aging Research)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The final dataset will include self-reported demographic and health history data from assessments with 57 older adults who are caregivers for individuals with ADRD.
Data from this research will be made available to the public in the University of Rochester's institutional repository, UR Research, at https://urresearch.rochester.edu.
We will share the research protocols, in a text format, such as MS Word or PDF.
Any qualitative data will also be made available in text form.
For quantitative data, the PI will make available the actual datasets generated from research, in a commonly- used format such as a SAS® dataset.
The datasets will be associated with a related publication, research protocol or other documentation of the original research.
IPD Sharing Time Frame
Timetable to release the data: the data and referenced resources from publications will be made available by the on-line publication date.
IPD Sharing Access Criteria
The investigators will make the data and associated documentation available to users only under a data-sharing agreement as suggested by the NIH that provides for: (1) a commitment to using the data only for research purposes and not to identify any individual participant; (2) a commitment to securing the data using appropriate computer technology; and (3) a commitment to destroying or returning the data after analyses are completed.
4. De-identification of data from human subjects: A final complete database will be created to host all data which will be stripped of any identifiers and stored pursuant to UR Institutional Review Board protocols.
Confidentiality for research subjects for qualitative data will be promoted by the use of an anonymization scheme and anonymizing the data as the qualitative files are created for the analysis (following guidelines developed by the Inter-university Consortium for Political and Social Research, 2012).
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Loneliness
-
Vladimíra DostálováBarcelona Institute for Global HealthRecruiting
-
Taipei Medical UniversityCompleted
-
Linkoeping UniversityUniversity College, LondonCompleted
-
KTO Karatay UniversityCompleted
-
Florida State UniversityCompleted
-
Heartfulness InstituteCompletedLonelinessUnited States
-
Trustees of Dartmouth CollegeRecruiting
-
University of OregonNational Institute on Drug Abuse (NIDA); HopeLab FoundationCompleted
-
University Hospital, BonnThe German-Israeli Foundation for Scientific Research and Development; Prof...Unknown
Clinical Trials on Social Engage Coaching
-
University of RochesterNational Institute of Mental Health (NIMH)RecruitingQuality of Life | Loneliness | Social Isolation | Suicide IdeationUnited States
-
University of RochesterNational Institute on Aging (NIA)Completed
-
University of RochesterNational Institute on Aging (NIA)CompletedLoneliness | Social Isolation | Caregiver BurnoutUnited States
-
University of RochesterNational Institute of Mental Health (NIMH)Recruiting
-
University of Maryland, BaltimoreNational Institute on Aging (NIA)Not yet recruiting
-
Washington University School of MedicineCompleted
-
University of California, Los AngelesCompleted
-
University of California, Los AngelesCompletedMental Disorders | Social Determinants | Financial Coaching | Medical-Financial Partnership | Toxic StressUnited States
-
University of California, Los AngelesCompletedQuality of Life | Socioeconomic StatusUnited States
-
University of California, Los AngelesCompletedChild Overall Health Related Quality of LifeUnited States